Subject Expert Committee

Bharat Biotech Asked For More Data By DCGI For Authorising Covaxin To Children Under 12

SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years

Biological E Applies For EUA For Covid-19 Vaccine Corbevax For 5-12 Age Group: Report

Amid Omicron Fear, Expert Committee Gives No Recommendations For COVID Booster Dose: Report

CDSCO Expert Panel Recommends Emergency Use Of Covaxin For Children Aged Between 2-18

Bharat Biotech Gets Approval To Start Next Phase Of Clinical Trials Of 'Covaxin' On Children Aged 2-18 Years

Expert Panel Gives Nod To Bharat Biotech’s Covaxin For Restricted Emergency Use